title: The influence of maternal disease on metabolites measured as part of newborn screening.
abstract: OBJECTIVE
  Measurements of neonatal metabolites are commonly used in newborn screening (NBS) programs to detect inborn errors of metabolism. Variation in these metabolites, particularly in infants born preterm (<37 weeks gestation), can result from multiple etiologies. We sought to evaluate the impact of maternal complications of pregnancy and environmental stressors on NBS metabolites.
  
  
  METHODS
  We examined 49 metabolic biomarkers obtained from routine NBS in 452 infants born preterm for association with maternal environmental stressors and complications of pregnancy.
  
  
  RESULTS
  Neonatal free carnitine (C0, p = 1.4 × 10(-7)), acetylcarnitine (C2, p = 2.7 × 10(-7)), octenoylcarnitine (C8:1, p = 5.2 × 10(-11)) and linoleoylcarnitine (C18:2, p = 9.1 × 10(-7)) were elevated in infants born to preeclamptic mothers. Similar elevations were observed in small for gestational age infants and in infants where labor was not initiated prior to delivery. When accounting for all three factors, associations remained strongest between acylcarnitines and preeclampsia.
  
  
  CONCLUSIONS
  We observed that maternal conditions, particularly preeclampsia, influence NBS biomarkers. This is important for identifying maternal conditions that influence metabolites measured during routine NBS that are also markers of fetal growth and overall health.
authors.affiliation: Department of Pediatrics, University of Iowa, Iowa City, IA 52242, USA. kelliryckman@uiowa.edu
authors.forename: Kelli K
authors.initials: KK
authors.lastname: Ryckman
authors.forename: Oleg A
authors.initials: OA
authors.lastname: Shchelochkov
authors.forename: Daniel E
authors.initials: DE
authors.lastname: Cook
authors.forename: Stanton L
authors.initials: SL
authors.lastname: Berberich
authors.forename: Sara
authors.initials: S
authors.lastname: Copeland
authors.forename: John M
authors.initials: JM
authors.lastname: Dagle
authors.forename: Jeffrey C
authors.initials: JC
authors.lastname: Murray
mesh_terms: D000108:Acetylcarnitine / Q000097:blood*; D000409:Alanine / Q000097:blood; D015415:Biomarkers / Q000097:blood; D005260:Female; D005312:Fetal Blood / Q000378:metabolism*; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D015999:Multivariate Analysis; D015997:Neonatal Screening; D011225:Pre-Eclampsia / Q000097:blood*; D011247:Pregnancy; D012189:Retrospective Studies
chemical_list: D015415:Biomarkers; D000108:Acetylcarnitine; D000409:Alanine
references.citation: Am J Physiol Endocrinol Metab. 2003 Jun;284(6):E1098-105
references.pmid: 12582009
references.citation: Amino Acids. 2010 Mar;38(3):959-72
references.pmid: 19468821
references.citation: Mol Genet Metab. 2011 Dec;104(4):476-9
references.pmid: 21908220
references.citation: Obstet Gynecol. 2004 May;103(5 Pt 1):876-80
references.pmid: 15121560
references.citation: Am J Obstet Gynecol. 1996 May;174(5):1575-83
references.pmid: 9065132
references.citation: Reproduction. 2003 Jun;125(6):785-90
references.pmid: 12773100
references.citation: Placenta. 2002 May;23(5):447-50
references.pmid: 12061861
references.citation: Hypertension. 2010 Oct;56(4):741-9
references.pmid: 20837882
references.citation: Reprod Sci. 2008 Jul;15(6):591-7
references.pmid: 18492697
references.citation: J Perinatol. 2007 Nov;27(11):672-80
references.pmid: 17855807
references.citation: J Obstet Gynaecol Br Commonw. 1971 Mar;78(3):215-31
references.pmid: 5558838
references.citation: Pediatr Res. 2007 Nov;62(5):630-5
references.pmid: 17805208
references.citation: Am J Obstet Gynecol. 1989 Nov;161(5):1219-27
references.pmid: 2589443
references.citation: Am J Obstet Gynecol. 1990 Jan;162(1):253-61
references.pmid: 2301500
references.citation: Eur J Endocrinol. 2011 Jun;164(6):1027-34
references.pmid: 21393448
references.citation: Pediatrics. 2010 Nov;126(5):910-6
references.pmid: 20974783
references.citation: Zhonghua Fu Chan Ke Za Zhi. 1996 Aug;31(8):468-70
references.pmid: 9275438